-
公开(公告)号：US20150289875A1
公开(公告)日：2015-10-15
申请号：US14253719
申请日：2014-04-15
Applicant: Abbott Cardiovascular Systems Inc.
Inventor： Paul Consigny , Erik Eli , Stephen D. Pacetti , Mikael Trollsas , John Stankus , Julia Fox
CPC classification number: A61B17/11 , A61B2017/1107 , A61B2017/1135 , A61F2/064 , A61F2/848 , A61F2/856 , A61F2/89 , A61F2/91 , A61F2/954 , A61F2/958 , A61F2/966 , A61F2002/821 , A61F2002/828 , A61F2002/91575 , A61F2002/9583 , A61M1/3655
Abstract: Medical devices and methods for forming an arteriovenous (AV) fistula include a stent having an arterial tubular portion and vein supporting tongue connected by a pre-shaped connector and a venous frustoconical stent having a distal end for maintaining a take-off angle for the venous portion of the AV fistula. Also disclosed is an angled balloon for assisting with the formation of the AV fistula. The medical devices disclosed herein support an AV fistula formation having a desired take off angle of about 30 degrees, or between about 15 and 45 degrees.
Abstract translation: 用于形成动静脉（AV）瘘的医疗装置和方法包括具有动脉管状部分和通过预形连接器连接的静脉支撑舌片的支架和具有用于维持静脉的起飞角度的远端的静脉截头圆锥形支架 部分AV瘘。 还公开了一种用于辅助AV瘘形成的成角度的球囊。 本文公开的医疗装置支持AV瘘形成，其具有约30度或约15度至45度的期望的脱离角度。
-
Patent Agency Ranking
公开(公告)号：US09687239B2
公开(公告)日：2017-06-27
申请号：US14253719
申请日：2014-04-15
Applicant: Abbott Cardiovascular Systems Inc.
Inventor： Paul Consigny , Erik Eli , Stephen D. Pacetti , Mikael Trollsas , John Stankus , Julia Fox
IPC: A61F2/06 , A61B17/11 , A61F2/91 , A61F2/954 , A61F2/856 , A61F2/89 , A61F2/958 , A61M1/36 , A61F2/848 , A61F2/966 , A61F2/82 , A61F2/915
CPC classification number: A61B17/11 , A61B2017/1107 , A61B2017/1135 , A61F2/064 , A61F2/848 , A61F2/856 , A61F2/89 , A61F2/91 , A61F2/954 , A61F2/958 , A61F2/966 , A61F2002/821 , A61F2002/828 , A61F2002/91575 , A61F2002/9583 , A61M1/3655
Abstract: Medical devices and methods for forming an arteriovenous (AV) fistula include a stent having an arterial tubular portion and vein supporting tongue connected by a pre-shaped connector and a venous frustoconical stent having a distal end for maintaining a take-off angle for the venous portion of the AV fistula. Also disclosed is an angled balloon for assisting with the formation of the AV fistula. The medical devices disclosed herein support an AV fistula formation having a desired take off angle of about 30 degrees, or between about 15 and 45 degrees.
-
公开(公告)号：US09737641B2
公开(公告)日：2017-08-22
申请号：US15445670
申请日：2017-02-28
Applicant: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Inventor： Stephen D. Pacetti , Julia Fox
CPC classification number: A61L31/08 , A61K31/436 , A61L31/143 , A61L31/16 , A61L2300/416 , A61L2420/02 , B65B55/12 , Y10T29/49885
Abstract: This invention relates to an method of manufacture of an implantable medical device comprising an oxygen-sensitive rapamycin derivative that is protected by addition of an antioxidant during the manufacturing process where the amount of antioxidant added at the outset of the processing is such that when the device is fully fabricated, sterilized and packaged the amount of antioxidant has reduced to a minimal, preferably non-detect, amount.
-
公开(公告)号：US20170173222A1
公开(公告)日：2017-06-22
申请号：US15445670
申请日：2017-02-28
Applicant: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Inventor： Stephen D. PACETTI , Julia Fox
IPC: A61L31/08 , A61L31/16 , A61L31/14 , A61K31/436
CPC classification number: A61L31/08 , A61K31/436 , A61L31/143 , A61L31/16 , A61L2300/416 , A61L2420/02 , B65B55/12 , Y10T29/49885
Abstract: This invention relates to an method of manufacture of an implantable medical device comprising an oxygen-sensitive rapamycin derivative that is protected by addition of an antioxidant during the manufacturing process where the amount of antioxidant added at the outset of the processing is such that when the device is fully fabricated, sterilized and packaged the amount of antioxidant has reduced to a minimal, preferably non-detect, amount.
-
公开(公告)号：US09610385B2
公开(公告)日：2017-04-04
申请号：US13789473
申请日：2013-03-07
Applicant: Abbott Cardiovascular Systems Inc.
Inventor： Stephen D. Pacetti , Julia Fox
CPC classification number: A61L31/08 , A61K31/436 , A61L31/143 , A61L31/16 , A61L2300/416 , A61L2420/02 , B65B55/12 , Y10T29/49885
Abstract: This invention relates to an method of manufacture of an implantable medical device comprising an oxygen-sensitive rapamycin derivative that is protected by addition of an antioxidant during the manufacturing process where the amount of antioxidant added at the outset of the processing is such that when the device is fully fabricated, sterilized and packaged the amount of antioxidant has reduced to a minimal, preferably non-detect, amount.
-
6.发明申请Method Of Fabricating An Implantable Medical Device Comprising A Rapamycin Derivative 有权制造包含雷帕霉素衍生物的可植入医疗器械的方法公开(公告)号：US20140250836A1
公开(公告)日：2014-09-11
申请号：US13789473
申请日：2013-03-07
Applicant: ABBOTT CARDIOVASCULAR SYSTEMS INC.
Inventor： Stephen D. Pacetti , Julia Fox
CPC classification number: A61L31/08 , A61K31/436 , A61L31/143 , A61L31/16 , A61L2300/416 , A61L2420/02 , B65B55/12 , Y10T29/49885
Abstract: This invention relates to an method of manufacture of an implantable medical device comprising an oxygen-sensitive rapamycin derivative that is protected by addition of an antioxidant during the manufacturing process where the amount of antioxidant added at the outset of the processing is such that when the device is fully fabricated, sterilized and packaged the amount of antioxidant has reduced to a minimal, preferably non-detect, amount.
Abstract translation: 本发明涉及一种可植入医疗器械的制造方法，该方法包括在制造过程中加入抗氧化剂而保护的氧敏感雷帕霉素衍生物，其中在处理开始时添加的抗氧化剂的量使得当该装置 完全制造，灭菌和包装，抗氧化剂的量已经减少到最小，优选不检测的量。
-
-
-
-
-
Search Results
6
records
(took 0.014 seconds)
